leadf
logo-loader

Barclays bullish on Brent as COVID vaccines promise oil demand boost

Barclays sees Brent crude at around US$53 per barrel in 2021.

Barclays bullish on Brent crude as COVID vaccines promise demand boost

Barclays said it is remaining bullish on crude oil prices for next year on the assumption that the rollout of COVID vaccines will ease impacts of the pandemic, thus driving a recovery in economic activity and oil demand.

The bank’s analysts pitch their above consensus Brent crude forecast at around US$53 per barrel, current price cUS$45.72.

At the same time, Barclays sees the West Texas Intermediary (WTI) crude at US$50 per barrel in 2021.

Away from the pandemic factors, meanwhile, OPEC and Russia are speculated to be close to postponing an envisaged hike in crude production quotas. A 2mln barrel per day rise was slated for January and it is suggested that it could move out three months.

Today, Brent crude is up around 1.8% changing hands at US$45.77 per barrel whilst WTI was 1.6% higher at US$43.10.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Mountain Valley MD files a patent for dosed adjuvant with potential...

Mountain Valley MD (CSE: MVMD) Director of Life Sciences Mike Farber joined Steve Darling from Proactive with news the company has applied for a patent to cover a novel dose sparing adjuvant with a potential application for Polio IPV delivery and the broader category of vaccines. Farber gives...

18 minutes ago

2 min read